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REVIEW ARTICLE
Psychometric properties of the Beck Depression
Inventory-II: a comprehensive review
Yuan-Pang Wang,1 Clarice Gorenstein1,2
1Institute & Department of Psychiatry (LIM-23), School of Medicine, Universidade de Sa˜o Paulo (USP), Sa˜o Paulo, SP, Brazil. 2Institute of
Biomedical Sciences, Department of Pharmacology, USP, Sa˜o Paulo, SP, Brazil.
Objective: To review the psychometric properties of the Beck Depression Inventory-II (BDI-II) as a
self-report measure of depression in a variety of settings and populations.
Methods: Relevant studies of the BDI-II were retrieved through a search of electronic databases, a
hand search, and contact with authors. Retained studies (k = 118) were allocated into three groups:
non-clinical, psychiatric/institutionalized, and medical samples.
Results: The internal consistency was described as around 0.9 and the retest reliability ranged from
0.73 to 0.96. The correlation between BDI-II and the Beck Depression Inventory (BDI-I) was high and
substantial overlap with measures of depression and anxiety was reported. The criterion-based
validity showed good sensitivity and specificity for detecting depression in comparison to the adopted
gold standard. However, the cutoff score to screen for depression varied according to the type of
sample. Factor analysis showed a robust dimension of general depression composed by two
constructs: cognitive-affective and somatic-vegetative.
Conclusions: The BDI-II is a relevant psychometric instrument, showing high reliability, capacity to
discriminate between depressed and non-depressed subjects, and improved concurrent, content, and
structural validity. Based on available psychometric evidence, the BDI-II can be viewed as a cost-
effective questionnaire for measuring the severity of depression, with broad applicability for research
and clinical practice worldwide.
Keywords: Psychometric scale; depression; reliability; validity; classical testing theory; item
response theory
Introduction
Depression is projected to become a globally prevalent
disorder1,2 with a huge burden to the population.3 Among
the available self-assessment instruments, the 21-item
Beck Depression Inventory (BDI) is one of the most
popular measures of depressive symptoms worldwide.4
First proposed by Beck et al.,5 this instrument has been
used in more than 7,000 studies so far. The theoretical
assumption of the original BDI relied upon the belief that
negativistic distorted cognitions would be the core
characteristic of depression.6
The BDI has undergone two major revisions: in 1978 as
the BDI-IA7 and in 1996 as the Beck Depression
Inventory-II (BDI-II).8 The updated BDI-II taps psycholo-
gical and somatic manifestations of 2-week major
depressive episodes, as operationalized in the DSM-
IV.9 This version was modified to reword and replace
some items. Four items of the BDI-IA that proved less
sensitive for identification of typical symptoms of severe
depression – weight loss, distorted body image, somatic
preoccupation, and inability to work – were dropped and
replaced by agitation, worthlessness, difficulty concen-
trating, and energy loss to assess a distinctive degree of
intensity of depression. In addition, the items on appetite
and sleep change were amended to evaluate the
increase and decrease of these depression-related
behaviors. Unlike the original version, the BDI-II does
not reflect any particular theory of depression.
Despite widespread use in both non-clinical and clinical
studies for more than 15 years after its publication, to the
best of our knowledge, no relevant summary of the
performance of this version has been conducted. In addition,
the last decade has seen major progress in psychometric
theories that were not fully developed at the time the BDI
was reformulated. Within this context, we carried out a
search of articles dealing with the psychometric properties of
the BDI-II. This review is not intended to be a systematic
review or meta-analysis, but a synopsis of the subject matter
addressing the feasibility of using BDI-II in different
population samples. Whenever possible, psychometric
advantages and criticisms are underscored, discussing
recommendations for use in a variety of settings.
Methods
Both investigators, with previous experience in psycho-
metric instruments, searched MEDLINE and PsycINFO
Correspondence: Yuan-Pang Wang, Nu´cleo de Epidemiologia
Psiquia´trica (LIM-23), Departmento & Instituto de Psiquiatria,
Faculdade de Medicina, Universidade de Sa˜o Paulo, Rua Dr. Ovı´dio
Pires de Campos, 785, CEP 05403-010, Sa˜o Paulo, SP, Brazil.
E-mail: gnap_inbox@hotmail.com
Submitted Nov 09 2012, accepted Feb 13 2013.
Revista Brasileira de Psiquiatria. 2013;35:416–431
 2013 Associac¸a˜o Brasileira de Psiquiatria
doi:10.1590/1516-4446-2012-1048
databases. The following MeSH terms were used to filter
relevant studies: psychometrics and depression. We
restricted the search to articles containing the BDI and
published between the time periods of January 1st, 1996
and October 10th, 2012. The following non-psychometric
article types were left out: clinical trials, editorials, letters,
meta-analyses, practice guidelines, randomized con-
trolled trials, and case reports. There was no language
or age range restriction.
All retained articles were read for exclusion of additional
criteria: non-psychometric studies; other versions of the
BDI; small samples (fewer than 30 participants10), unless
the study addressed a very important problem, such as
between-version comparison or content analysis.
Secondary analyses of previously reported datasets were
excluded. Summary analysis of the complete sample was
preferable when multiple analyses were available (such as
separate reports by gender, ethnicity, or depressed vs.
non-depressed groups).
The reference sections of review articles11-13 and book
chapters4,14,15 that were not retrieved in the computer
search were examined to identify potential studies for
inclusion. Additional efforts to locate relevant studies
included contacting authors in the field and a hand search
of the reference lists of retained articles.
Results and discussion
Overview
The MeSH search strategy detailed above yielded 2,611
articles. Filtering these studies using BDI resulted in 253
articles, 198 of which matched the time period of interest.
The exclusion of non-psychometric study types narrowed
the sample to 178 articles. Among those retained from
the electronic database plus hand search, 60 did not
meet the inclusion criteria: 33 articles did not present
relevant psychometric data; 18 used the BDI-I; five used
the BDI-Fast Screen; and four presented a small sample.
The final list resulted in 118 articles dedicated to
investigate psychometric performance of the BDI-II.
For the sake of comparison between similar investiga-
tions, the studies were grouped by sample recruitment
source as: non-clinical (k = 47); psychiatric/institutiona-
lized (k = 37); or medical samples (k = 34). Typically, non-
clinical studies were conducted in student analogue
depression samples (average age, 18-23 years), which
are referred to in this study as student studies to describe
university-recruited samples (k = 29) and adolescent
studies to describe school-based underage respondents
(k = 8). Psychiatric samples were stratified as inpatient,
outpatient, or institutionalized. Medical samples were
grouped according to the disease and recruitment setting.
The instrument was applied to over 60,000 respondents.
The English version of the BDI-II has been translated
into 17 languages, and is used in Europe, the Middle
East, Asia, and Latin America (Table 1). Although the
English version prevailed among the studies (65%), the
increasing number of language versions suggests inter-
national acceptance of the instrument.
Table 1 shows that the mean score ranged from 5.1 to
38.4. In general, psychiatric samples presented the
highest mean scores, medical samples intermediate,
and non-clinical samples the lowest means. Since sample
standardization is not demographically representative of
the population and little evidence has been provided
regarding the gender and culture fairness of the items
and total score, the original authors recommended
development of local norms.
Reliability
Twenty-nine of the 118 retrieved articles (25%) did not
report reliability coefficients, indicating that the assump-
tion of test score reliability generally has not prevailed in
clinical practice regarding application of the BDI. In
comparison to the internal consistency of the previous
versions of the BDI (average Cronbach’s alpha coefficient
around 0.85),8 most studies on BDI-II reported an
average alpha coefficient around 0.9, ranging from 0.83
to 0.96 (Table 1). Probably, the replacement of particular
items has improved the homogeneity of the scale. Its
ability to assess different types of depression, e.g.,
atypical depression, is superior to that of the BDI-IA, as
symptoms of increased and decreased appetite and
sleep were included in the BDI-II items. However,
superior reliability does not necessarily indicate improve-
ment of the clinical validity of the scale.
Retest reliability (Pearson’s r) showed relative stability
through re-application of the BDI-II, with good to excellent
coefficients (range, 0.73 to 0.96),17,29,33,59,127 with a
mean re-application interval of 2 weeks (range, 1 week
to 6 months) for the majority of studies (82%). However,
two remarks should be taken into account when
interpreting these coefficients: 1) as true changes in
depressive symptoms can occur without any intervention,
while a high correlation is more likely after a short time,
a longer interval could explain a smaller correlation;
2) there is no available retest information for patient
samples, whether psychiatric or medical. The observed
retest coefficients were similar to the values found by the
authors of the BDI-II with clinical and non-clinical
populations,8 0.92 and 0.93 respectively for an average
time interval of 7 days between application and the re-
application of the scale. A reliability generalization
analysis showed an average coefficient around 0.65 for
the previous version of the BDI.128 Comparison of the
retest coefficients of the BDI-I and BDI-II could only be
considered definitive if the time intervals of the studies
were similar.
To address the potential source of this retest effect,
Longwell & Truax129 randomly assigned non-clinical
participants (n=237) without intervention to complete the
BDI-II at weekly, monthly, or bimonthly intervals. Scores
were found to significantly decrease for the weekly
administration group only, indicating that lower retest
scores could be the result of a measurement effect and
the frequency of administration. Re-application of the
BDI-II in healthcare settings might be problematic, since
lower scores, or true change in severity of depression,
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Table 1 Studies using the BDI-II by language version, sample size, target sample, gender distribution, mean (SD) score, and reliability (alpha
and Pearson’s r)
Author, year Language n Sample %F Mean score (SD) Alpha Pearson’s r
Non-clinical samples (47)
Beck, 19968 English 120 Student 44 12.6 (9.9) 0.93 0.93
Aasen, 200116 Norwegian 303 Student 70 7.1 (6.0) 0.86 0.77
875 Adult 59 8.1 (7.5) 0.91
Al-Musawi, 200117 Arabic 200 Student 63 13.4 (6.7) 0.84 0.75
Al-Turkait & Ohaeri, 201018 Arabic 624 Student 71 15.5 (8.5) 0.83
Aratake, 200719 Japanese 399 Worker 33 12.3 (8.3) 0.90
Arnarson, 200820 Icelandic 1,206 Student 72 8.8 (7.8) 0.91 0.89
Byrne, 200421 Chinese 1,460 Adolescent 53 NR 0.91-0.94 0.74
Campos & Gonc¸alves, 201122 Portuguese 538 Student 60 8.9 (7.9) 0.90
200 Adult 50 NR 0.91
Canel-C¸inarbas, 201123 Turkish 340 Student 1 46 14.9 (9.2) 0.88
English 487 Student 2 55 10.1 (7.7) 0.90
Carmody, 200524 English 502 Student 54 12.8 (9.1) 0.92
Coelho, 200225 Portuguese 775 Adolescent 60 10.3 (8.4) 0.89
Cunningham, 200826 English 971 Adolescent 51 12.9 (10.3) NR
Dozois, 199827 English 1,022 Student 67 9.1 (7.6) 0.91
Gary & Yarandi, 200428 English 206 Rural Women 100 8.7 (7.8) 0.91
Ghassemzadeh, 200529 Persian 125 Student 50 9.8 (8.0) 0.87 0.73
Glickmann, 200430 English 546 Student 57 11.3 (9.7) 0.92
Gorenstein, 201131 Portuguese 3,410 Student 1 71 10.9 (8.2) 0.88
60 Student 2 52 NR NR 0.89
1,417 Adolescent 60 11.7 (9.3) 0.89
301 Elderly 61 10.4 (10.1) 0.89
182 Adult 56 9.9 (10.7) 0.93
Holla¨ndare, 200832 Swedish 71 Student/Teacher 30 7.3-9.4 (7.4-11.1) 0.94-0.95
Kapci, 200833 Turkish 362 Worker 61 14.1 (9.7)*
15.0 (9.2)
{
0.90 0.94
Kneipp, 200934 English 308 Low-income women 100 17.1 (12.0)
{
18.5 (11.8)
{
0.94
Kogan, 200435 English 114 Elderly 62 6.6 (5.4) NR
Kojima, 200236 Japanese 766 Worker 42 8.9 (6.5) 0.87
Ku¨hner, 200737 German 89 Adult 1 51 7.7 (7.5) 0.89 0.78
118 Adult 2 61 7.7 (7.5)
108 Student 61 7.7 (7.5) 0.78
Lipps, 200738 English 690 Student 77 9.8 (8.6)*
11.7 (9.3)
{
0.90
Lipps, 201039 English 278 Adolescent 52 13.0-23.0 (2.9-23.9) 0.90
Maga´n, 200840 Spanish 249 Adult 53 NR NR
Osman, 199741 English 230 Student 68 9.4 (6.4)*
11.9 (8.7)
{
0.90
Osman, 200842 English 414 Adolescent 49 12.5 (10.5) 0.92
Pallensen, 200643 Norwegian 304 Student 44 NR NR
879 Adult 58
Roberts, 201244 Welsh 115 Student 82 5.1 (5.9) 0.90
Rodrı´guez-Go´mez, 200645 Spanish 410 Elderly 77 7.9 (7.6) 0.89
Sanz, 200346 Spanish 590 Student 78 9.2 (7.5) 0.89
Sanz, 200347 Spanish 470 Adult 53 9.4 (7.7) 0.87
Sashidharan, 201248 English 278 Student 75 9.4 (3.6) 0.91
Segal, 200849 English 229 Student 64 9.1 (8.5) 0.92
147 Elderly 58 7.7 (6.4) 0.86
Shean & Baldwin, 200850 English 395 Student 48 5.5 (4.2)
1
14.8 (6.6)
I
0.86
Sprinkle, 200251 English 137 Student 1 58 10.5 (7.7)
1
27.6 (9.8)
I
NR
46 Student 2 61 15.8 (10.4)
"
13.8 (9.6)**
0.91
0.93
0.96
Steer & Clark, 199752 English 160 Student 67 11.9 (8.1) 0.89
Storch, 200453 English 414 Student 73 11.1 (8.2) 0.90
Trevin˜o, 200754 English 196 Hispanic couples 50 9.7 (9.7) NR
Uslu, 200855 Turkish 512 Adolescent 55 11.0-13.8 (8.2-10.6)*
13.8-15.0 (8.6-9.7)
{
0.90 0.89
Vanheule, 200856 Dutch 695 Adult 50 7.0 (7.0) NR
Whisman, 200057 English 576 Student 58 8.4 (7.2) 0.89
Whisman, 201258
{{
English 7,369 Student 65 9.3 (8.1) 0.90
Wiebe & Penley, 200559 English 539 Student 1 59 NR 0.89 0.73
Spanish 355 Student 2 59 NR 0.91 0.86
Bilingual subsample (n=254) 59 11.5 (9.2)
{{
9.8 (9.3)
11
11.7 (7.4)
11
10.3 (9.0)
{{
NR 0.76
Wu, 201060 Chinese 997 Student 60 13.0 (8.4) 0.88
Wu & Huang, 201261 Chinese 827 Adolescent 50 12.2 (8.7) NR
Continued on next page
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Table 1 Continued
Author, year Language n Sample %F Mean score (SD) Alpha Pearson’s r
Psychiatric/institutionalized samples (37)
Beck, 19968 English 500 Adult outpatients 63 22.5 (12.8) 0.92
Bedi, 200162 English 390 Women outpatients 100 29.6 (11.9) 0.83-0.87
Besier, 200863 German 111 Adolescent outpatients 62 14.4 (10.8)
1
24.3 (12.2)
I
0.92
Brouwer, 201264 Dutch 1,530 Adult outpatients 62 20.1 (10.8) 0.90
Brown, 201265 English 111 Chronic fatigue outpatients 83 17.7 (9.1) 0.89
Buckley, 200166 English 416 Substance user inpatients 0 22.1 (11.5) 0.91
Cole, 200367 English 101 Psychiatric inpatients 55 17.5 (12.3) 0.95
Delisle, 201268 English 1,498 Psychiatric outpatients 68 27.5 (11.5)*
29.8 (12.0)
{
NR
Dolle, 201269 German 88 Adolescent outpatients 58 10.5 (8.9)
1
31.6 (9.6)
I
0.94
Dum, 200870 English 108 Substance user outpatients 52 19.2 (13.6) 0.95
Hepner, 200971 English 240 Substance user inpatients 37 14.9 (11.0) 0.91
Hiroe, 200572 Japanese 85 Adult patients 59 11.2-42.2 (NR) NR
Joe, 200873 English 133 Suicide attempt outpatients 62 30.6 (14.4) 0.94
Johnson, 200674 English 598 Drug user outpatients 24 15.8 (10.8) 0.92
Kapci, 200833 Turkish 176 Adult outpatients 69 28.2 (12.6)*
30.4 (11.4)
{
0.89
Krefetz, 200275 English 100 Adolescent inpatients 56 24.7 (12.5) 0.92
Krefetz, 200376 English 240 Adolescent outpatients 60 23.9 (11.9) 0.89
Ku¨hner, 200737 German 13 Acute depressed inpatients 69 33.1 (9.4) 0.84 0.47
Ku¨hner, 200737 German 23 Non-remitted depressed
inpatients
57 33.1 (9.4) 0.84 0.47
Ku¨hner, 200737 German 52 Previously depressed patients 48 10.5 (8.8) 0.90 0.47
Kumar, 200277 English 100 Adolescent inpatients 55 22.8 (15.8) 0.94
Kung, 201278 English 625 Adult depressed in/outpatients NR 31.0 (13.1) NR
Lindsay & Skene, 200779 English 108 Patients with intellectual disability 26 14.1 (NR) 0.90
O’Hara, 199880 English 152 Student outpatients 70 15.3 (11.0) NR
Osman, 200442 English 13 Adolescent inpatients 46 NR NR
408 Adolescent inpatients 50 13.4-22.5 (10.7-14.5) 0.93
(319 adolescent inpatients) 50 NR
Osman, 200881 English 167 Adolescent inpatients 60 23.1 (11.4) 0.90
Palmer & Binks, 200882 English 117 Institutionalized male offenders 0 17.4 (11.2) 0.90
Perris & Gilbody, 200983 English 256 Institutionalized prisoners 47 NR NR
394 100 NR NR
Quilty, 201084 English 425 Adult outpatients 67 29.9 (8.8) NR
Roberts, 201244 Welsh 37 Depression patients 60 38.4 (11.9) 0.96
Sanz, 200585 Spanish 305 Adult outpatients 75 22.1 (11.5) 0.89
Seignourel, 200886 English 582 Substance user outpatients 55 20.6 (11.8) 0.93
Steer, 199887 English 210 Adolescent outpatients 50 18.2 (12.7) 0.92
Steer, 199988 English 210 Depressed outpatients 50 28.6 (11.8) 0.90
Steer, 200089 English 130 Geriatric inpatients 62 24.6 (12.8) 0.89
Uslu, 200855 Turkish 166 Adolescent outpatients 68 24.7 (10.3)*
31.7 (13.3)
{
0.90
Van Noorden, 201290 Dutch 1,489 Adult outpatients 62 31.0 (9.6) NR
Vanheule, 200856 Dutch 404 Adult outpatients 71 26.0 (12.0) NR
VanVoorhis & Blumentritt, 200791 English 131 Institutionalized adolescents 28 13.7-20.9 (11.1-13.4) 0.90
Medical samples (34)
Arnarson, 200820 Icelandic 248 Adult – Primary care 82 21.3 (12.2) 0.93
Arnau, 200192 English 333 Adult – Primary care 69 8.7 (9.4) 0.94
Bunevicius, 201293 Lithuanian 522 Adult – Hospital 28 11.0 (8.2) 0.85
Carney, 200994 English 140 Insomnia – Hospital 74 14.1 (10.2) 0.91
Carvalho Bos, 200995 Portuguese 331 Pregnancy – Primary care 100 NR 0.88
354 Postpartum – Primary care 100 0.89
Chilcot, 201196 English 460 Renal disease – Hospital 35 11.9 (8.3) NR
Chung, 201097 Chinese 62 Heart disease – Hospital 31 18.2 (7.9) NR
Corbie`re, 201198 French 206 Chronic pain – Hospital 53 17.2 (11.5) 0.84
del Pino Pe´rez, 201299 Spanish 205 Coronary patients – Hospital 26 9.2 (7.6) NR
Di Benedetto, 2006100 English 81 Acute coronary syndrome –
Hospital
19 NR . 0.90
Dutton, 2004/Grothe, 2005101,102 English 220 Adult – Primary care 52 12.6 (10.4) 0.90
Frasure-Smith & Lespe´rance,
2008103
English/French 804 Coronary patients – Hospital 19 NR 0.90
Hamid, 2004104 Arabic 493 Adult – Primary care 100 13.0 (8.1) NR
Harris & D’Eon, 2008105 English 481 Chronic pain – Hospital 58 26.9 (11.7) 0.92
Hayden, 2012106 English 83 Bariatric surgery – Hospital 71 13.4 (9.1) 0.89
Jamroz-Wisniewska, 2007107 Polish 104 Multiple sclerosis – Hospital 74 14.4 (9.2) NR
Jones, 2005108 English 174 Epilepsy – Hospital 66 NR 0.94
Kirsch-Darrow, 2011109 English 161 Parkinson disease – Hospital 31 9.5 (7.2) 0.89
Lopez, 2012110 English 345 Chronic pain – Hospital 0 23.0 (12.2) 0.93
Low & Hubley, 2007111 English 119 Coronary patients – Hospital 25 8.0 (7.1) 0.89
Mahmud, 2004112 Malay 61 Postpartum – Primary care I 100 4.4 (5.5) 0.89
354 Postpartum – Primary care II 6.2 (6.4)
Continued on next page
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can be obtained even without intervention and might be
attributable to the measurement process. The measure-
ment error due to time length as captured by the retest
estimate is probably larger than the error due to item
heterogeneity and content as captured by cross-sectional
internal consistency.128
On the other hand, Hiroe et al.72 investigated sensitivity
to change by anchoring the BDI-II against the Clinical
Global Impression-Change (CGI-I) subscale 2 weeks
after first consultation of 40 patients with major depres-
sion. The instrument was able to distinguish between all
grades of depression severity. Since changes in score
could also be the result of a measurement effect,
clinicians should be careful when making important
treatment decisions based solely on information from
the BDI-II.
Item characteristics
The true score of a given scale, as well as its reliability, is
the result of a set of scores that are susceptible to the
influence of individual item errors.130 Further analysis of
item characteristics might overcome this measurement
effect.
In comparison with its previous version, the item
characteristics of the BDI-II have been changed in terms
of item endorsement rate, content coverage, and homo-
geneity. Most investigations of non-clinical samples
reported item scores in the low end of the possible range
(0-3), resulting in a skewed distribution of item scores.
Typically, non-clinical participants tended to report an
average item score below 1.31,131 Furthermore, the mean
item score does not exceed 2 in most clinical samples. In
the case of extreme scores, endorsement bias might
push the distribution of the results upward. Some
researchers have criticized the possibility of malingered
or deceitful ratings by the respondents due to the self-
report nature of the scale.75,83,86 The potential fakability
of the inventory should be kept in mind during the
interpretation of the test.
The item suicidal thoughts had the lowest endorsement
rate; however, the substantial correlation still provides
evidence of its contribution to the measured construct.
Similarly, loss of sexual interest displayed the worst
item-total correlation, although it remained significantly
related to the whole construct under consideration.8,31
Conversely, somatic items such as change in sleeping
pattern and in appetite also presented low scores for
non-clinical samples. The hypothesis of gender differ-
ences in somatic symptoms132 was not supported by
Delisle et al.,68 who showed that the experience and
reporting of somatic symptoms could explain merely a
small portion of discrepancy in depressed patients.
Testing the hypothesis of whether individual baseline
depressive symptoms in the interest-activity domain
would predict outcome, the items pessimism and loss of
energy were found to be independent predictors of both
remission and response in the treatment setting.90 The
effects of new items and wording revisions on the
psychometric performance of the scale have not been
fully assessed, and sample type should be taken into
account when interpreting scores.
Because the selected items and content of the BDI-II
were modified in accordance with symptoms defined in
the DSM-IV as specific to a subtype of depression, it is
reasonable to expect a more stringent degree of
homogeneity. Beck8 reported a median item-total scale
correlation of 0.59 for the BDI-II in a sample of college
students (n=120). Acceptable item-total scale correla-
tions (rit o 0.5)
10 were described for 17 out of 21 items.
Nonetheless, this correlation can vary across studies. For
the Arabic version, substantial item-total correlation was
described for 10 items among Islamic students,131 whereas
adequate item-total correlation of the Portuguese version
in Brazilian samples was reported for 15 items.31 Factors
such as language version, type of sample, age range,
educational level, and severity of depression might affect
the difficulty of item endorsement.133 Insight into which
items should be assigned to a scale can improve its
performance through item-level analysis.
Table 1 Continued
Author, year Language n Sample %F Mean score (SD) Alpha Pearson’s r
Ooms, 2011113 Dutch 136 Tinnitus – Hospital 35 11.3 (9.5) NR
Patterson, 2011114 English 671 Hepatitis C – Hospital 3 16.2 (12.2) 0.84-0.91
Penley, 2003115 English/
Spanish
122 Hemodialysis – Hospital 41 15.0 (12.5) 0.92
Poole, 2006, 2009116,117 English 1,227 Chronic pain – Hospital 62 24.4 (11.7) 0.92
Rampling, 2012118 English 266 Epilepsy – Hospital 59 NR 0.94
Siegert, 2009119 English 353 Neurorehabilitation – Hospital 40 13.6 (10.1) 0.89
Su, 2007120 Chinese 185 Pregnant – Hospital 100 7.0 (5.0)
1
17.0 (10.2)
I
NR
Thombs, 2008121 English/French 477 Myocardial infarction – Hospital 17 9.2 (7.9) NR
Tully, 2011122 English 226 Cardiac surgery – Hospital 17 8.6 (6.2)
II
0.85
9.1 (6.4)
""
0.87
Turner, 2012123 English 72 Stroke – Primary care 47 13.4 (12.9) 0.94
Viljoen, 2003124 English 127 Adult – Primary care 63 NR NR
Warmenhoven, 2012125 Dutch 46 Cancer – Hospital 43 14.7 (9.9) NR
Williams, 2012126 English 229 Parkinson disease – Primary care 33 6.5 (5.2)
1
14.7 (7.4)
I
0.90
BDI-II = Beck Depression Inventory-II; NR = not reported; SD = standard deviation.
* Men, { women, { half-random sample, 1 non-depressed, I depressed, " first administration, ** second administration, {{ sample included
some of the dataset from previous reports, {{ English, 11 Spanish, II preoperative, "" postoperative.
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Item response theory and Rasch analysis
Most validation studies of the BDI-II were analyzed on the
grounds of classic test theory (CTT), assuming a true
score for each respondent and disregarding the measure-
ment error. In other words, two individuals with the same
total score may differ in terms of the relative severity and
frequency of symptoms. In CTT, most test performances
are computed as a whole rather than at the item level.
Error is often assumed to be normally distributed and
uncorrelated with the true score. Although the statistics
produced are usually generalized to similar respondents
taking a similar test, the results should only apply to those
individuals taking that test. As a psychometric break-
through to these limitations, latent trait models based on
item response theory (IRT) aim to look beyond the CTT:
at the underlying traits that are producing the test
performance. The results of an IRT-based test can
provide sample-free measurement and are measured at
the item level in terms of difficulty and discrimination. This
method is being increasingly used in the empirical
construction and evaluation of modern psychometric
instruments.
A sound rating scale should measure a single
psychopathological construct (i.e., an illness or syn-
drome) and be composed of items that adequately cover
a constellation of symptoms that are associated with the
syndrome. According to IRT, a given scale and its
constituent items may have good reliability estimates
but still fail to meet IRT criteria of unidimensionality.134
Efforts to analyze individual items and to identify a single
dimension of depression severity can benefit from several
IRT models, e.g., Rasch analysis. This method assesses
the extent to which empirical data correspond to an ideal
dimension, by identifying a unidimensional set of items
from a rating scale, and evaluates how adequately these
items measure the full range of clinical severity.
Use of the IRT is particularly pressing in studies
investigating clinical change in depressive syndromes.
Items that are insensitive to change will underestimate
the strength of actual treatment effects. In contrast, a true
treatment effect can be weakened if patients are falsely
identified as not having changed, thus leading to spurious
claims of ineffectiveness of the therapeutic intervention. If
only items measuring mild depression were used to
compose a depression scale, it would be very difficult to
discriminate between moderate and severe cases of
depression with this instrument, since high scores on all
items would characterize both states.
The magnitude to which a severity score actually
measures depression is related to a unidimensional
syndrome. When depression is heterogeneous, the
interpretation of a single summed score is unclear. For
example, if items assessing psychological and physical
symptoms were only loosely related, a single score would
not distinguish between two potentially different groups of
depressed patients – with primarily psychological or with
primarily vegetative symptoms. Any effects of an inter-
vention targeting only one of these aspects would be
harder to detect.
Subsequently, a subset of BDI-II items that would
measure a single dimension of depression across a wide
range of severity can be sensitive at mild, moderate, or
severe levels. IRT analysis can improve the scale items in
a psychometrically stronger fashion. When disturbed
thresholds are identified, item rescoring may be neces-
sary. One expects diverse item ratings at different levels
of severity, with zeroes more frequent at mild levels of
overall depression and higher item scores more common
with more severe presentations of depression. Moreover,
whereas most items on the BDI-II are sensitive to the
level of depression severity, many items may present
response options that can be considered awkward, at the
very least.
Seigert et al.119 examined each BDI-II item for
differential item functioning in a neurological sample
(n=315). Three items (changes in sleeping pattern,
changes in appetite, and loss of interest in sex) were
removed in an iterative fashion after identification of misfit
to model expectations. Possibly, these items measure
different dimensions. In the real world, the likelihood of
receiving a rating of 1 on the insomnia item was
essentially the same regardless of the overall severity
of depression, but the likelihood of receiving a rating of 3
on sad mood was very low even when overall depression
was severe. These findings suggest that the rating
scheme was not ideal for many BDI-II items, decreasing
its capacity to detect change. Additional applications of
this type of technique include detection of translation or
equivalence problems between language versions at the
item level.23
Measurement invariance is a prerequisite for consider-
ing the equivalence of the scale across versions, as well
as for using it to make valid and interpretable compar-
isons of the severity of depression among different
groups. Applying the IRT-related item functioning analy-
sis, Hambrick et al.135 compared response patterns of
African American and Asian American undergraduates to
those of white counterparts on measures of depression,
social anxiety, and worry. While the response patterns of
African American participants were roughly equivalent to
those of their white counterparts, there were substantial
differences in measures of worry and social anxiety.
Using a mixed item response model incorporating both
latent class and Rasch analysis, Wu & Huang136 showed
that person heterogeneity (e.g., different response usage
and styles) of a student sample could reflect two latent
classes without compromising scale construct validity.
These investigations are examples of how the family of
IRT techniques can address several psychometric ques-
tions at the item level, beyond the summed score of CTT.
Concurrent and discriminant validity
Table 2 displays studies that report a comparison of the
BDI-II with scales measuring depression, anxiety, and
miscellaneous constructs as criterion, determined at
essentially the same time to check for concurrent validity.
The convergent validity between the BDI-I and the BDI-II
was high, with Pearson’s product-moment correlation
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coefficients (r) ranging from 0.82 to 0.94.27,33,137 The
overlap of the construct measured by BDI-II with that of
other widely used scales to assess depression, e.g., the
Center for Epidemiologic Studies of Depression (CES-D),
the Hamilton Depression Rating Scale (HAM-D), the
Zung Self-Rating Depression Scale (SDS), the
Montgomery-A˚sberg Depression Rating Scale
(MADRS), and the Geriatric Depression Scale (GDS),
was also quite high, ranging from 0.66 to 0.86 (Table 2).
Researchers and clinicians need to be aware of the
different constructs covered by depression instruments,
which, while supposedly measuring the same attribute,
might be focused on different components of this mood
condition. Although BDI-II was designed to be a non-
theoretically driven instrument, its coverage seems to be
broader than the intended DSM-IV description of major
depression.
The convergent validity between the BDI-II and scales
that assess anxiety – such as the Beck Anxiety Inventory
(BAI), the Hamilton Anxiety Rating Scale (HAM-A), and
the State-Trait Anxiety Inventory (STAI) – was also
significant, with a wide range of correlation coefficients
(0.37 to 0.83; rough estimate of 0.50). On the other hand,
overlap between the BDI-II and scales that assess
general psychopathology (e.g., K10 and Self-Report
Questionnaire [SEQ]) was good to excellent.31,123
These significant concurrent correlations are expected
and might be linked to the underlying constructs and the
characteristics of the instruments. This overlap between
anxiety and depressive symptoms is indicative of
symptomatic co-occurrence as well as of the high rate
of comorbidity of these clinical syndromes. As depression
is one of the broadest indicators of mental health, a high
score on the BDI scale could be explained by many other
disorders, physical illness, or social problems. In this
respect, BDI should not be viewed as a specific indicator
of depression. In practice, BDI-II scores can be mis-
interpreted, leading the clinician to assume depression
as a primary issue, when used without a thorough
assessment.
Table 2 Concurrent and discriminant validity of the Beck Depression Inventory-II with measures of depression, anxiety, and
other miscellaneous constructs*
Construct/Concurrent instrument r Study
Depression measure
BDI-I - Beck Depression Inventory – I 0.82-0.94 27,33,137
CES-D - Center for Epidemiologic Studies of Depression 0.66-0.86 20,22,36,38,40,49,50,98
HRSD - Revised Hamilton Rating Scale for Depression 0.66-0.75 73,111,137
MADRS - Montgomery-A˚sberg Depression Rating Scale 0.68-0.75 31,37
SCL-90-D - Symptom Check List – Depression 0.57-0.84 16,18
Z-SRDS - Zung Self-Rating Depression Scale 0.71 16
PHQ-9 - Patient Health Questionnaire (PRIME-MD) 0.74-0.88 37,70,71,78,123
EPDS - Edinburgh Postnatal Depression Scale 0.72-0.74 111
HADS-D - Hospital Anxiety and Depression Scale – Depression 0.71-0.77 20,89,123
DASS-D - Depression Anxiety Stress Scales – Depression 0.77 41
GDS - Geriatric Depression Scale 0.76 110
Anxiety measure
BAI - Beck Anxiety Inventory 0.56-0.69 16,20,26,33,37,40-43,52,137
HARS - Revised Hamilton Anxiety Rating Scale 0.47-0.66 31,137
STAI - State-Trait Anxiety Inventory 0.37-0.83 17,43,53,99,105
SCL-90-A - Symptom Check List – Anxiety 0.48-0.57 18
MASQ - Mood Anxiety Symptom Questionnaire 0.46-0.71 41
PSWQ - Penn State Worry Questionnaire 0.56-0.61 20,43
HADS-A - Hospital Anxiety and Depression Scale-Anxiety 0.61-0.66 20,44,102
DASS-A - Depression Anxiety Stress Scales – Anxiety 0.44 41
MOCI - Maudsley Obsessive Compulsive Inventory 0.45 43
Miscellanea
K10 - Kessler’s 10-item brief screening scale 0.63-0.93 31,123
SRQ-20 - Self-Report Questionnaire 0.67-0.89 31
DASS-S - Depression Anxiety Stress Scales – Stress 0.68 41
PSS - Perceived Stress Scale 0.67 49
SCL-90-P - Symptom Check List, Psychoticism scale 0.61 16
CISQ - Checklist of Individual Strength Questionnaire 0.66 19
BSI - Brief Symptom Inventory 0.67 33
SPWB - Short Psychological Well-Being Scale 0.65 49
WHOQOL - WHO Quality of Life 0.30-0.78 37
WHO-5 - WHO Wellbeing Index 0.49-.73 37
SSI - Scale for Suicide Ideation 0.37 8
SBQ-R - Suicidal Behaviors Questionnaire-Revised 0.51-0.60 42,81
BHS - Beck Hopelessness Scale 0.55-0.69 8,26,33,42,81,82
AUDIT - Alcohol Use Disorders Identification Test 0.17-0.33 70,71
DAST - Drug Abuse Screening Test 0.26 70
MPQ PRI - McGill Pain Questionnaire Pain Rating Index 0.32 105
r = Pearson’s product-moment correlation. Negative correlation is omitted in the numerical value.
* A complete list of retrieved studies can be obtained from the authors upon request.
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Concerning discriminant validity, studies have indi-
cated low correlation (r , 0.4) with instruments assessing
alcohol and drug use70,71 and chronic pain.105 It is
noteworthy that suicidal ideation, which is one of the
core features of depression and an item on the BDI-II,
correlated only poorly to moderately with the instru-
ment.8,81 More investigations should be conducted to
document concurrent validity in comparison with well-
known constructs.
Although the construction of the BDI-II adopted a non-
theoretical strategy, the high concurrent validity between
scales assessing depressive and anxiety states (and, to
a lesser extent, the poor discriminant validity between
BDI-II and other constructs) suggest the need for a
theoretical model to elucidate the relationship, whether
similarity or dissimilarity, between these disorders. In
light of empirical structural evidence, Watson & Clark’s
contributions on a psychopathological construct named
negative affect138-140 advocated that the boundaries of
mood and anxiety disorders might be collapsed together
into an overarching class of emotional disorders and
further decomposed into some meaningful subclasses of
disorders.
Criterion-oriented validity
Based on the scores of 500 outpatients recruited from
four clinics, the original authors of the instrument8
proposed the following rules of thumb for score inter-
pretation with different specifiers of severity: 0-13 to
indicate minimal or no depression; 14-19, mild depres-
sion; 20-28, moderate depression; and 29-63, severe
depression. For instance, the average BDI-II score in this
patient sample with mood disorders was M=26.6. Mean
scores for major depressive episode, recurrent depres-
sion, and dysthymia were, respectively, 28.1, 29.4, and
24.0.
Although the instrument was originally designed to
measure the severity of depression, existing evidence
shows that the BDI-II can be recommended to screen for
probable cases of major depression (Table 3). In general,
studies reported a sensitivity ofo 0.70. Sensitivity should
be viewed as the most important indicator to minimize the
chance of false-negative diagnosis of depressive dis-
orders. Significant diagnostic accuracy, as expressed by
the area under the receiver operating characteristics
(ROC) curve, was around 75% and higher. Sources of
Table 3 Criterion validity and cutoff point of the Beck Depression Inventory-II to detect major depressive episode
Author Cutoff Sn Sp PPV NPV AUC %MDD Criterion
Non-clinical sample
Dozois27 13 81 92 NR NR NR NR BDI-II . 12
Gorenstein31 10 70 87 84.3 77 82 33.5 SCID-I
Osman81 10 86.8 56.8 NR NR 77 10.5 Clinical consensus
Sprinkle51 16 84 73 NR NR NR 64.0 SCID-I
Shean & Baldwin50 10 73.3 84.4 47.8 94.2 NR 17.9 DIS-IV
Psychiatric/institutionalized sample
Dolle69 23 88 92 NR NR 93 27 Kinder-DIPS
Kapci33 19 77 76 NR NR 87 NR Clinical
Krefetz75 24 74 70 NR NR 78 NR PRIME-MD
Kumar77 21 85 83 85 83 92 54 PRIME-MD
Perry & Gilbody83 21
31*
65.9
80.0
67.9
60.4
NR NR 74
75
32.6
14
SCOPE
Seignourel86 25 73 75 45 91 82 21.3 SCID-I
Uslu55 20 77.4 76.8 63.4 84.6 86 NR BDI-II . 12
Medical sample
Arnarson20 20 82 75 NR NR 87 42.1 MINI
Arnau92 18 94 92 54 99 96 23.2 PHQ
Bunevicius93 14 89 74 29 98 90 11 MINI
Carney94 17 81 79 NR NR 83.8 NR SCID-I
Dutton102 14 87.7 839 695 942 91 29.5 PRIME-MD
Frasure-Smith & Lespe´rance103 14 91.2 77.5 NR NR 92 13.7 SCID-I
Jones108 11 96 80 48 99 94 17.2 MINI
15 84 87 55 97 92 SCID-I
11 95.7 78.3 42 99 94 MINI + SCID
Low & Hubley111 10 100 75 21 100 92 11.8 SCID-I
Rampling118 14 93.6 74 44 98 90 17.7 MDI (ICD-10)
15 93.8 78.9 49.5 98 93 18 MDI (DSM-IV)
Turner123 11 92 71 NR NR 89 18 SCID-I
Warmenhoven125 16 90 69 NR NR 82 22 PRIME-MD
Williams126 7 95 60 62 94 85 34.1 SCID-I
AUC = area under the curve; DIS-IV = Diagnostic Interview Schedule-IV; Kinder-DIPS = Diagnostisches Interview bei psychischen
Sto¨rungen im Kindes und Jugendalter; MDI = Major Depression Inventory; MINI: Mini International Neuropsychiatric Interview; NPV =
negative predictive value; NR = not reported; PHQ = PRIME-MD Patient Health Questionnaire; PPV = positive predictive value; PRIME-MD =
primary care evaluation of mental disorders; SCID-I = Structured Clinical Interview for DSM-IV Axis I Diagnosis; SCOPE: measure of
vulnerability to suicide and self-harm behavior; Sn = sensitivity; Sp = specificity; %MDD = proportion of major depressive disorder in the
sample.
* This investigation included incident cases of suicide.
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variation may depend on the type of the sample (non-
clinical or clinical), percentage of depressive subjects,
and external gold-standard criterion for DSM-IV depres-
sion. As shown in Table 3, non-clinical samples displayed
the lowest range of cutoff points (from 10 to 16) to detect
major depression, medical samples had an intermediate
cutoff (from 7 to 20), and psychiatric samples had the
highest cutoff (from 19 to 31). However, caution is
warranted when using the cutoff guidelines presented
for criterion-referenced interpretation and regarding
misuse of the BDI-II as a diagnostic instrument. While
the reported thresholds are helpful indicators for detecting
suspected cases that should be referred for additional
clinical assessment, the validity of these findings is
essentially limited by the arbitrary external criterion
adopted for comparison. Regardless of sound criterion
validity, most investigators were unanimous in recom-
mending the BDI-II as a screening tool as the first
phase of two-stage studies to prevent excessive cases of
false-positive detection if the scale is used as a single
tool.50
Some BDI-II items were associated with treatment
response in a treatment setting.90 In the regression
model, the items pessimism and loss of energy emerged
as predictors of response after 2 years. When both
symptoms were endorsed at baseline, these items
could predict a 61.1% chance of response, and absence
of both symptoms predicted a 49.4% chance of
response. Routine clinical assessment of these depres-
sive symptoms can provide information about treatment
progress as early as the initial assessment of the
intake phase.
Content and construct validity
Besides test performance and criteria scores, the under-
lying trait or quality of a given test is a matter of the
utmost importance for its validity.141 Two relevant topics
are the description of content validity and the latent
construct assessed by the instrument.142 While content
coverage was established by ordinary deduction of the
universe of items accepted to define the construct,
structural or construct validity can be demonstrated
by statistical methods, such as factor analyses. The
development of a sound measurement instrument for
large-scale use requires demonstration of the latent trait
being measured, and of the types, categories, and
behaviors that constitute an adequate representation of
depression.
The content validity of the BDI-II appears to be
adequate but narrower than that of its former version.10,42
The BDI-I reflected six of the nine criteria for DSM-based
depression,143,144 while the BDI-II presented an improved
performance on specificity to indicate DSM-based
depression. Consequently, the sensitivity of the test to
detect a broader concept of depression may have been
affected.27,50 The acceptance of the content universe as
a qualitative representation of the trait to be measured is
critical in this type of validity.130 Although this DSM-based
instrument for assessment of depression can allow
reliable comparisons in an array of settings and facilitates
tailoring of therapeutic interventions, this trend should not
be viewed as the true representation of the construct of
depression.145
Construct validity tests how well a given psychological
measure relates to measures of theory-driven constructs.
Therefore, construct validation refers to the simultaneous
procedure of measurement and theory validation.146,147
However, since the BDI-II was built on non-theoretical
assumptions, investigators often choose factor analysis
to account for variance in test performance and deter-
mine which psychological events make up test perfor-
mance. Besides reducing the items to explain the
structure of data covariance, factor analysis depicts the
latent structure of a given test. This family of techniques
can determine how and to what extent selected items
cluster on one or more factors.148 Table 4 lists 74
investigations reporting the factor structure of BDI-II,
which represented around two-thirds of the retained
studies, grouped by type of sample and specified strategy
for factor extraction. Some investigators have adopted
both exploratory and confirmatory strategies with different
purposes, e.g., to identify problems with items reported to
have non-significant factor loadings, or for cross-valida-
tion of data. The use of the state-of-art confirmatory
approach is a trend in studies investigating the latent
structure of BDI-II.
Using the means of exploratory factor analysis, Beck8
reported a structure of two oblique factors, repre-
sented by the cognitive-affective and somatic-vegetative
dimensions (between-factor correlation, r = 0.62 and 0.66
for student and outpatient samples respectively). A
similar two-dimensional structure was obtained in non-
clinical samples using a different language version of the
BDI-II,27,31,55 in psychiatric samples,8,33,55,62,65,82,88,91
and in medical patients.96,114,116,124 The between-factor
correlation coefficients in the two-dimensional structure of
the BDI-II were generally high (. 0.50, range 0.49-0.87)
and could account for a large amount of common data
variance. Meta-analysis of selected empirical studies on
the factor structure of the BDI concluded that much of the
data variability can be attributed to the common dimen-
sion of severity of depression and the other part to
somatic symptoms.12 However, some investigators also
reached different results, with more than two dimensions
and different item loadings.21,45,70 These conflicting
findings posited the existence of alternative structural
models.
The confirmatory strategy has been employed to
compare the structure and model fit of previous studies
in relation to the construct validity of the BDI-II. In general,
a two-dimensional structure composed of a cognitive-
affective and a somatic-vegetative factor can be repli-
cated empirically across studies.27,29,38,53,57,59 The
stability of the obtained solutions seems to substantiate
the proposal of the DSM-IV, where the cognitive-affective
symptoms are central to making the diagnosis, supple-
mented by the vegetative-somatic symptoms in the
assessment of depressive syndrome. Nevertheless,
some studies have suggested that the structure of
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Table 4 Construct validity of latent structure of the Beck Depression Inventory-II
Author Sample Method Factor 1 Factor 2 Factor 3 Factor 4
Non-clinical sample (34)
Beck8 Students EFA Cognitive-affective Somatic-vegetative
Aasen16 Students CFA Negative attitude Performance difficulty Somatic element
Adults Negative attitude Performance difficulty Somatic element
Al-Musawi17 Students EFA Cognitive-affective Overt emotional upset Somatic complaints
CFA Cognitive-affective Emotional distress Somatic-vegetative
Al-Turkait & Ohaeri18 Students CFA Cognitive-affective Somatic General depression (G)
Arnarson20 Students CFA Depressive cognition Depressive affect Somatic-vegetative
Byrne21 Students EFA Negative attitude Performance difficulty Somatic element
CFA Negative attitude Performance difficulty Somatic element (Depression)
Campos & Gonc¸alves22 Students EFA Cognitive-affective Somatic
Adults CFA Cognitive-affective Somatic
Canel-C¸inarbas23 Turkish students CFA Cognitive-affective Somatic
U.S. students
Carmody24 Students CFA Negative attitude Performance difficulty Somatic
Dozois27 Students EFA Cognitive-affective Somatic-vegetative
CFA Cognitive-affective Somatic-vegetative
Gary & Yarandi28 Rural women EFA Cognitive Somatic-affective
Ghassemzadeh29 Students CFA Cognitive-affective Somatic-vegetative
Gorenstein31 College students EFA Cognitive-affective Somatic-vegetative
Adolescents EFA Cognitive-affective Somatic-vegetative
Elderly EFA Cognitive-affective Somatic-vegetative
Kapci33 Workers EFA
CFA
Performance
difficulty/Somatic
Negative attitude
Kneipp34 Low-income women EFA Cognitive-affective Somatic
CFA Cognitive-affective Somatic General depression (G)
Kojima36 Workers PCA Somato-vegetative Cognitive-affective
CFA Somato-vegetative Cognitive-affective
Lipps38 Students C-PCA Cognitive-affective Somatic-vegetative
Osman41 Students CFA Negative attitude Performance difficulty Somato-vegetative
Osman42 Adolescents CFA Somatic Cognitive-affective General depression (G)
Roberts44 Students EFA Cognitive-affective Somatic-vegetative (Depression)
Rodriguez-Gomes45 Elderly PCA Somatic Cognitive-behavioral Biological Negative attitude
Sanz46 Students EFA Cognitive-affective Somatic-motivational General depression (G)
Sanz47 Community EFA Cognitive-affective Somatic-motivational General depression (G)
Segal49 Students PCA Depression
Elderly
Steer & Clark52 Students EFA Cognitive-affective Somatic-vegetative
Storch53 Students CFA Cognitive-affective Somatic-vegetative
Uslu55 Adolescents EFA Cognitive Somatic-affective
Vanheule56 Community CFA Somatic-vegetative Depressive affect Depressive cognition
Whisman57 Students CFA Cognitive-affective Somatic-vegetative
Whisman58 Students CFA Negative attitude Performance difficulty Somatic elements (Depression)
Wiebe & Penley59 Students CFA Cognitive-affective Somatic-vegetative
Wu60 Students CFA Negative attitude Performance difficulty Somatic elements
Wu & Huang61 Adolescents CFA Negative attitude Performance difficulty Somatic elements
Psychiatric/institutionalized sample (24)
Beck8 Outpatients EFA Cognitive-affective Somatic-vegetative
Bedi62 Depressed women EFA Somatic-affective Cognitive
Brouwer64 Outpatients CFA Affective Cognitive Somatic General
depression (G)
Brown65 Chronic fatigue EFA Cognitive Somatic-affective
Buckley66 Substance abusers CFA Cognitive Affective Somatic
Cohen149 Outpatients MDS Disturbance Arousal
Cole67 Psychiatric inpatients PCA Cognitive-affective Somatic-vegetative (Depression)
Dum70 Substance users PCA Somatic Affective Cognitive
Hepner71 Substance users CFA Cognitive Somatic
Joe73 Suicide attempters CFA Somatic Cognitive-affective (Depression)
Johnson74 Intravenous drug users CFA Cognitive Affective Somatic
Kapci33 Outpatients EFA Somatic-affective Cognitive
CFA
Lindsay & Skene79 Intellectual disability PCA Emotion cognitions Loss of function Somatic changes
Osman42 Adolescent outpatients CFA
EFA
Cognitive Somatic
Palmer & Binks82 Male offenders EFA Cognitive-affective Somatic
Quilty84 Major depression CFA Cognitive Somatic General depression (G)
Sanz47 Outpatients EFA Somatic-motivational Cognitive General depression (G)
Seignourel86 Substance users CFA Cognitive Affective Somatic
Steer87 Adolescent outpatients EFA Cognitive Somatic-affective Guilt/Punishment (Depression)
Steer88 Depressed outpatients EFA Somatic-affective Cognitive
CFA Cognitive Non-cognitive (Depression)
Steer85 Geriatric inpatients EFA Somatic-affective Cognitive
Uslu55 Adolescents EFA Somatic-affective Cognitive
Vanheule56 Outpatients CFA Somatic-vegetative Depressive affect
VanVoorhis &
Blumentritt91
Mexican American
adolescents
EFA Cognitive-somatic Affective
Continued on next page
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BDI-II can be best described as three-dimensional,
distributing the cognitive-affective dimension into two
distinct factors.17,20,41,56,66,98,122,136 Further analyses
revealed that the BDI-II presents reasonable factorial
invariance when assessing the severity of depressive
symptoms; this covariance structure is equivalent across
gender and ethnicity in American college students58 and
across gender in Taiwanese college students and
adolescents.60,61
Sophisticated alternative structural analysis of the BDI-
II was strengthened by two investigative breakthroughs:
the hierarchical model and the bifactor model. The first
group of strategies depicted a general depression
dimension as a higher-order structure to explain the
variance of lower-order dimensions.21,58,67,73,87,101,105
Although still scant, the bifactor model (G) was able to
identify a non-hierarchical general depression in
addition to the traditional two-dimensional struc-
ture.18,34,64,81,84,96,121 These investigations shared the
view that much of the variance of the BDI-II items can be
accounted for by a hierarchical higher order or a parallel
dimension of depression, where much of the common
variance can be explained by a general construct.
Practitioners should be careful when interpreting sub-
scale scores, which might be greatly related to the
heterogeneous characteristics of depressive conditions.
Cross-cultural issues
With the BDI-II being such a popular measure adapted
for use in several countries, information on cross-
cultural comparability is still remarkably scarce. The
cross-cultural equivalence between the versions of
the BDI-II stands out as a topic of fervent academic
interest: the symptomatology of depression in different
culture/races or languages can be compared by testing
the measurement variance of the instrument.23,48,58,59,150
For example, large differential item functioning values
were found for 12 BDI-II items between Turkish and U.S.
students with same level of depression.23 Besides
suggesting an equivalence problem with the Turkish
version, this study indicated that participants would
respond in a different way to different language versions
of the instrument. Likewise, the construct validity of the
BDI-II (Table 4) also varies over existing language
versions. Before a true cross-cultural difference can be
acknowledged, more fine-grained analyses should be
conducted to ascertain the sources of this dissimilarity.
Limitations
Before widespread adoption of the BDI-II as a standard
measure of depression, the potential sources of its score
variation should be examined. First, this review has
attempted to minimize the file drawer bias by including
psychometric articles published in journals, monographs,
and book chapters. Explicit exclusion criteria were used
to select high-quality investigations. Moreover, efforts
were made to contact authors in the field to obtain
primary psychometric data for the BDI-II. Unlike tradi-
tional experimental studies, psychometric analyses are
more descriptive in nature, with both significant and non-
significant studies being available. Therefore, the pub-
lication bias seems to affect the current review to a lesser
degree than in experimental-type research.
The spectrum bias refers to the psychometric phenom-
enon of differential performance of a test in different
settings, thus affecting the generalizability of the results.
For example, the somatic factor can be the dominant
dimension in patient samples88 vs. depressive cognition
Table 4 Continued
Author Sample Method Factor 1 Factor 2 Factor 3 Factor 4
Medical sample (16)
Arnau89 Primary care PCA Somatic-affective Cognitive (Depression)
Carvalho Bos94 Pregnancy PCA Cognitive-affective Anxiety Fatigue
Postpartum PCA Cognitive-affective Somatic-anxiety Guilt
Chilcot96 Renal disease EFA Cognitive Somatic
CFA Cognitive Somatic General depression (G)
Corbie`re98 Chronic pain CFA Cognitive Affective Somatic
del Pino Pe´rez97 Coronary disease EFA Somatic-affective Cognitive
CFA Somatic-affective Cognitive (Depression)
Grothe101 Medical outpatients CFA Cognitive Somatic (Depression)
Harris & D’Eon105 Chronic pain CFA Negative attitude Performance difficulty Somatic (Depression)
Kirsch-Darrow108 Parkinson’s disease CFA Dysphoric mood Loss of interest/pleasure Somatic
Lopez109 Chronic pain EFA Negative rumination Somatic Complaint Mood
Mahmud111 Postpartum PCA Affective Somatic Cognitive
Patterson114 Hepatitis C EFA Cognitive-affective Somatic
CFA Cognitive-affective Somatic
Penley113 Hemodialysis CFA Cognitive Somatic-affective
Poole116 Chronic pain EFA Negative cognitions Behavior and activities
CFA
Siegert119 Neurorehabilitation PCA Cognitive-affective Somatic
CFA Cognitive-affective Somatic
Thombs121 Myocardial infarction CFA Cognitive Somatic General depression (G)
Tully122 Coronary revascularization CFA Cognitive Affective Somatic
Viljoen124 Primary care EFA Somatic-affective Cognitive
C-PCA = confirmatory principal component analysis; CFA = confirmatory factor analysis; EFA = exploratory factor analysis; MDS =
multidimensional scaling; PCA = principal component analysis; G = general factor of depression for bifactor model; Depression = higher-
order general dimension of depression for hierarchical model.
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in non-clinical samples. On the other hand, the workup or
verification bias arises when respondents with positive (or
negative) diagnostic procedure results are preferentially
referred to receive verification by the gold-standard
procedure, producing considerable distortion in test
accuracy. To the extent where these types of bias might
occur, the investigators should consider the differential
performance of the BDI-II when interpreting scores.
Future revisions should include quantitative analysis to
assess the sources of scale error.
The self-report nature of the BDI can affect its results
according to social desirability, respondent educational
attainment, and the gender effect of the condition.130 The
BDI is sometimes criticized for being too transparent to
respondents and thus easily faked by those wishing to
present themselves in a favorable or unfavorable light.
Fortunately, this does not seem to be a pervasive
problem, as the BDI-II tended to provide an accurate
index of depressive manifestations in voluntary and
anonymous participants, with good correlation with
measures of negative psychological states such as
anxiety or psychological distress. Furthermore, the non-
theoretical approach of the construction of the BDI-II
might introduce more problems than solutions for under-
standing the scale in terms of psychometric and clinical
parameters. In summary, despite its robust psychometric
characteristics, as widely reported in available studies,
the generalizability of the BDI-II is not free of limitations.
Comments
Depression is a common psychological state in both non-
clinical and clinical conditions. The predicted high
occurrence of depressive disorders worldwide justifies
the use of self-assessment scales to detect a consensus
definition of depression. These instruments must be
inexpensive and easy to administer, with good accep-
tance by users in the public health domain. The pressure
for rapid evidence-based decisions in clinical practice and
the explosion of information in the scientific literature
indicate the need for an updated review to summarize the
growing body of psychometric literature on self-report
measures of depression, such as the BDI-II.
A good measure must supply clinicians with evidence
that they find useful and relevant to the needs of their
patients. Advantages of this well-investigated inventory
are its high internal consistency, capacity to discriminate
between depressed and non-depressed subjects, and
improved content and structural validity. Consequently,
investigators can benefit from this simple, short, reliable,
and validated tool to design research in a variety of
settings. The fact that the BDI-II is copyrighted and must
be obtained from the publisher is the major obstacle
against the recommendation of its widespread use as a
standard second-generation self-report tool worldwide.
After more than 15 years using the BDI-II in hundreds
of investigations and thousands of respondents, evidence
of the validity of this authoritative scale is growing, but its
use is not free of caveats. Bearing in mind that the stated
purpose of the BDI-II was not to establish a diagnosis of
major depressive episode, continuous investigations
must examine its appropriateness in monitoring treatment
efficacy and its comparability with observer-rated scales,
such as the HAM-D or the MADRS. Besides comparing
the cross-cultural equivalence and conducting item-level
analysis to uncover the factors affecting the interpretation
of this scale for measurement of depressive symptoms,
future studies of the BDI-II should be mindful of theory-
based strategies of validation.
Acknowledgements
Fundac¸a˜o de Amparo a` Pesquisa do Estado de Sa˜o Paulo
(FAPESP) sponsors this article and Yuan-Pang Wang is
the recipient of the grant (protocol no. 2008/11415-9).
Conselho Nacional de Desenvolvimento Cientı´fico e
Tecnolo´gico (CNPq) sponsors Clarice Gorenstein.
Disclosure
The authors report no conflicts of interest.
References
1 Ferrari AJ, Somerville AJ, Baxter AJ, Norman R, Patten SB, Vos T,
et al. Global variation in the prevalence and incidence of major
depressive disorder: a systematic review of the epidemiological
literature. Psychol Med. 2013;43:471-81.
2 Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B.
Depression, chronic diseases, and decrements in health: results
from the World Health Surveys. Lancet. 2007;370:851-8.
3 World Health Organization (WHO). The Global burden of disease.
2004 Update. Geneva: WHO; 2008.
4 McDowell I. Measuring health: a guide to rating scales and
questionnaires. 3rd ed. New York: Oxford University; 2006.
5 Beck AT, Ward CH, Mendelson M, Mock JE, Erbaugh JK. An
inventory for measuring depression. Arch Gen Psychiatry.
1961;4:561-71.
6 Beck AT, Steer RA, Garbin MG. Psychometric properties of the
Beck Depression Inventory: twenty-five years of evaluation. Clin
Psychol Rev. 1988;8:77-100.
7 Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive therapy of
depression. New York: Guilford; 1979.
8 Beck AT, Steer RA, Brown GK. BDI-II: Beck Depression Inventory
Manual. 2nd ed. San Antonio: Psychological Corporation; 1996.
9 American Psychiatric Association. Diagnostic and statistical manual
of mental disorders - DSM-IV-TRH. 4th ed. Washington: American
Psychiatric Publishing; 1994.
10 Nunnally JC, Bernstein IH. Psychometric theory. New York:
McGraw; 1994.
11 Furukawa TA. Assessment of mood: guides for clinicians. J
Psychosom Res. 2010;68:581-9.
12 McPherson A, Martin CR. A narrative review of the Beck
Depression Inventory (BDI) and implications for its use in an
alcohol-dependent population. J Psychiatr Ment Health Nurs.
2010;17:19-30.
13 Shafer AB. Meta-analysis of the factor structures of four depression
questionnaires: Beck, CES-D, Hamilton, and Zung. J Clin Psychol.
2006;62:123-46.
14 Dozois DJA. Beck Depression Inventory-II. In: Weiner IB,
Craighead WE, editors. The Corsini Encyclopedia of psychology.
4th ed. New York: John Wiley & Sons; 2010. p. 210-1.
15 Kazdin AE. Encyclopedia of Psychology. Oxford: American
Psychological Association; 2000.
16 Aasen H. An empirical investigation of depression symptoms:
norms, psychometric characteristics and factor structure of the
Beck Depression Inventory-II. Bergen: University of Bergen; 2001.
Review of Beck Depression Inventory-II 427
Rev Bras Psiquiatr. 2013;35(4)
17 Al-Musawi NM. Psychometric properties of the beck depression
inventory-II with university students in Bahrain. J Pers Assess.
2001;77:568-79.
18 Al-Turkait FA, Ohaeri JU. Dimensional and hierarchical models of
depression using the Beck Depression Inventory-II in an Arab
college student sample. BMC Psychiatry. 2010;10:60.
19 Aratake Y, Tanaka K, Wada K, Watanabe M, Katoh N, Sakata Y,
et al. Development of Japanese version of the checklist individual
strength questionnaire in a working population. J Occup Health.
2007;49:453-60.
20 Arnarson TO, Olason DT, Smari J, Sigurethsson JF. The Beck
Depression Inventory Second Edition (BDI-II): psychometric proper-
ties in Icelandic student and patient populations. Nord J Psychiatry.
2008;62:360-5.
21 Byrne BM, Stewart SM, Lee PWH. Validating the Beck Depression
Inventory-II for Hong Kong community adolescents. Int J Testing.
2004;4:199-216.
22 Campos RC, Gonc¸alves B. The Portuguese version of the Beck
Depression Inventory-II (BDI-II): preliminary psychometric data with
two nonclinical samples. European J Psychol Assess. 2011;27:
258-64.
23 Canel-C¸inarbas D, Cui Y, Lauridsen E. Cross-cultural validation of
the Beck Depression Inventory-II across US and Turkish samples.
Meas Eval Couns Develop. 2011;44:77-91.
24 Carmody D. Psychometric characteristics of the Beck Depression
Inventory-II with college students of diverse ethnicity. Int J
Psychiatry in Clin Pract. 2005;9:22-8.
25 Coelho R, Martins A, Barros H. Clinical profiles relating gender and
depressive symptoms among adolescents ascertained by the Beck
Depression Inventory II. Eur Psychiatry. 2002;17:222-6.
26 Cunningham S, Gunn T, Alladin A, Cawthorpe D. Anxiety,
depression and hopelessness in adolescents: a structural equation
model. J Can Acad Child Adolesc Psychiatry. 2008;17:137-44.
27 Dozois DJA, Dobson K, Ahnberg J. A psychometric evaluation of
the Beck Depression Inventory-II. Psychol Assess. 1998;10:83-9.
28 Gary FA, Yarandi HN. Depression among southern rural African
American women: a factor analysis of the Beck Depression
Inventory-II. Nurs Res. 2004;53:251-9.
29 Ghassemzadeh H, Mojtabai R, Karamghadiri N, Ebrahimkhani N.
Psychometric properties of a Persian-language version of the Beck
Depression Inventory-Second edition: BDI-II-PERSIAN. Depress
Anxiety. 2005;21:185-92.
30 Glickman AR, La Greca AM. The Dating Anxiety Scale for
Adolescents: scale development and associations with adolescent
functioning. J Clin Child Adolesc Psychol. 2004;33:566-78.
31 Gorenstein C, Wang YP, Argimon IL, Werlang BSG. Manual do
Inventa´rio de Depressa˜o de Beck - BDI-II. Sa˜o Paulo: Casa do
Psico´logo; 2011.
32 Holla¨ndare F, Askerlund AM, Nieminen A, Engstro¨m I. Can the BDI-
II and MADRS-S be transferred to online use without affecting their
psychometric properties? E J Appl Psychol. 2008;4:3.
33 Kapci EG, Uslu R, Turkcapar H, Karaoglan A. Beck Depression
Inventory-II: evaluation of the psychometric properties and cut-off
points in a Turkish adult population. Depress Anxiety.
2008;25:E104-10.
34 Kneipp SM, Kairalla JA, Stacciarini J, Pereira D. The Beck
Depression Inventory II factor structure among low-income women.
Nurs Res. 2009;58:400-9.
35 Kogan JN, Edelstein BA. Modification and psychometric examina-
tion of a self-report measure of fear in older adults. J Anxiety Disord.
2004;18:397-409.
36 Kojima M, Furukawa TA, Takahashi H, Kawai M, Nagaya T,
Tokudome S. Cross-cultural validation of the Beck Depression
Inventory-II in Japan. Psychiatry Res. 2002;110:291-9.
37 Ku¨hner C, Burger C, Keller F, Hautzinger M. [Reliability and validity
of the Revised Beck Depression Inventory (BDI-II). Results from
German samples]. Nervenarzt. 2007;78:651-6.
38 Lipps GE, Lowe GA, Young R. Validation of the beck depression
inventory-II in a Jamaican university student cohort. West Indian
Med J. 2007;56:404-8.
39 Lipps GE, Lowe GA, Halliday S, Morris-Patterson A, Clarke N,
Wilson RN. The association of academic tracking to depressive
symptoms among adolescents in three Caribbean countries. Child
Adolesc Psychiatry Ment Health. 2010;4:16.
40 Maga´n I, Sanz J, Garcia-Vera MP. Psychometric properties of a
Spanish version of the Beck Anxiety Inventory (BAI) in general
population. Span J Psychol. 2008;11:626-40.
41 Osman A, Downs WR, Barrios FX, Kopper BA, Gutierrez PM,
Chiros CE. Factor structure and psychometric characteristics of the
Beck Depression Inventory-II. J Psychopathol Behav Assess.
1997;19:359-76.
42 Osman A, Kopper BA, Barrios F, Gutierrez PM, Bagge CL.
Reliability and validity of the Beck Depression Inventory-II
with adolescent psychiatric inpatients. Psychol Assess. 2004;16:
120-32.
43 Pallesen S, Nordhus IH, Carlstedt B, Thayer JF, Johnsen TB. A
Norwegian adaptation of the Penn State Worry Questionnaire:
factor structure, reliability, validity and norms. Scand J Psychol.
2006;47:281-91.
44 Roberts G, Roberts S, Tranter R, Whitaker R, Bedson E, Tranter S,
et al. Enhancing rigour in the validation of patient reported outcome
measures (PROMs): bridging linguistic and psychometric testing.
Health Qual Life Outcomes. 2012;10:64.
45 Rodriguez-Gomez JR, Davila-Martinez MG, Collazo-Rodriguez LC.
Factor structure of the Beck Depression Inventory-Second Edition
(BDI-II) with Puerto Rican elderly. P R Health Sci J. 2006;25:
127-32.
46 Sanz J, Navarro ME, Valverde CV. Adaptacio´n espan˜ola del
Inventario para la Depresio´n de Beck-II (BDI-II): 1. Propiedades
psicome´tricas en estudiantes universitarios. Anal Modificacio´n
Conducta. 2003;29:239-88.
47 Sanz J, Perdigo´n AL, Va´zquerz C. Adaptacio´n espan˜ola del
Inventario para la Depresio´n de Beck-II (BDI-II): 2. Propiedades
psicome´tricas em poblacio´n general. Clin Salud. 2003;14:249-80.
48 Sashidharan T, Pawlow LA, Pettibone JC. An examination of racial
bias in the Beck Depression Inventory-II. Cultur Divers Ethnic Minor
Psychol. 2012;18:203-9.
49 Segal DL, Coolidge FL, Cahill BS, O’Riley AA. Psychometric
properties of the Beck Depression Inventory-II (BDI-II) among
community-dwelling older adults. Behav Modif. 2008;32:3-20.
50 Shean G, Baldwin G. Sensitivity and specificity of depression
questionnaires in a college-age sample. J Genet Psychol.
2008;169:281-8.
51 Sprinkle SD, Lurie D, Insko SL, Atkinson G, Jones GL, Logan AR,
et al. Criterion Validity, severity cut scores, and test-retest reliability
of the Beck Depression Inventory-II in a University counseling
center sample. J Couns Psychol. 2002;49:381-5.
52 Steer RA, Clark DA. Psychometric characteristics of the Beck
Depression Inventory-II with college students. Meas Eval Couns
Develop. 1997;30:128-36.
53 Storch EA, Roberti JW, Roth DA. Factor structure, concurrent
validity, and internal consistency of the Beck Depression Inventory-
Second Edition in a sample of college students. Depress Anxiety.
2004;19:187-9.
54 Trevin˜o YA, Wooten HR, Scott RE. A correlational study between
depression and marital adjustment in hispanic couples. Fam J.
2007;15:46-52.
55 Uslu RI, Kapci EG, Oncu B, Ugurlu M, Turkcapar H. Psychometric
properties and cut-off scores of the Beck Depression Inventory-II
in Turkish adolescents. J Clin Psychol Med Settings. 2008;15:
225-33.
56 Vanheule S, Desmet M, Groenvynck H, Rosseel Y, Fontaine J. The
factor structure of the Beck Depression Inventory-II: an evaluation.
Assessment. 2008;15:177-87.
57 Whisman MA, Perez JE, Ramel W. Factor structure of the Beck
Depression Inventory-Second Edition (BDI-II) in a student sample. J
Clin Psychol. 2000;56:545-51.
58 Whisman MA, Judd CM, Whiteford NT, Gelhorn HL. Measurement
Invariance of the Beck Depression Inventory-Second Edition (BDI-
II) across gender, race, and ethnicity in college students.
Assessment. 2013;20:419-28.
59 Wiebe JS, Penley JA. A psychometric comparison of the Beck
Depression Inventory-II in English and Spanish. Psychol Assess.
2005;17:481-5.
60 Wu PC. Measurement invariance and latent mean differences of
the Beck Depression Inventory II across gender groups. J
Psychoeduc Assess. 2010;28:551-63.
YP Wang & C Gorenstein428
Rev Bras Psiquiatr. 2013;35(4)
61 Wu PC, Huang TW. Gender-Related Invariance of the Beck
Depression Inventory II for Taiwanese adolescent samples.
Assessment. 2012 Apr 18. [Epub ahead of print]
62 Bedi RP, Koopman RF, Thompson JM. The dimensionality of the
Beck Depression Inventory-II and its relevance for tailoring the
psychological treatment of women with depression. Psychother.
2001;38:306-18.
63 Besier T, Goldbeck L, Keller F. [Psychometric properties of the
Beck Depression Inventory-II (BDI-II) among adolescent psychiatric
patients]. Psychother Psychosom Med Psychol. 2008;58:63-8.
64 Brouwer D, Meijer RR, Zevalkink J. On the Factor Structure of the
Beck Depression Inventory-II: G Is the Key. Psychol Assess.
2013;25:136-45.
65 Brown M, Kaplan C, Jason L. Factor analysis of the Beck
Depression Inventory-II with patients with chronic fatigue syndrome.
J Health Psychol. 2012;17:799-808.
66 Buckley TC, Parker JD, Heggie J. A psychometric evaluation of the
BDI-II in treatment-seeking substance abusers. J Subst Abuse
Treat. 2001;20:197-204.
67 Cole JC, Grossman I, Prilliman C, Hunsaker E. Multimethod
validation of the Beck Depression Inventory-II and Grossman-
Cole Depression Inventory with an inpatient sample. Psychol Rep.
2003;93:1115-29.
68 Delisle VC, Beck AT, Dobson KS, Dozois DJ, Thombs BD.
Revisiting gender differences in somatic symptoms of depression:
much ado about nothing? PLoS One. 2012;7:e32490.
69 Dolle K, Schulte-Ko¨rne G, O’Leary AM, von Hofacker N, Izat Y,
Allgaier AK. The Beck Depression Inventory-II in adolescent mental
health patients: Cut-off scores for detecting depression and rating
severity. Psychiatry Res. 2012;200:843-8.
70 Dum M, Pickren J, Sobell LC, Sobell MB. Comparing the BDI-II and
the PHQ-9 with outpatient substance abusers. Addict Behav.
2008;33:381-7.
71 Hepner KA, Hunter SB, Edelen MO, Zhou AJ, Watkins K. A
comparison of two depressive symptomatology measures in
residential substance abuse treatment clients. J Subst Abuse
Treat. 2009;37:318-25.
72 Hiroe T, Kojima M, Yamamoto I, Nojima S, Kinoshita Y, Hashimoto
N, et al. Gradations of clinical severity and sensitivity to change
assessed with the Beck Depression Inventory-II in Japanese
patients with depression. Psychiatry Res. 2005;135:229-35.
73 Joe S, Woolley ME, Brown GK, Ghahramanlou-Holloway M, Beck
AT. Psychometric properties of the Beck Depression Inventory-II in
low-income, African American suicide attempters. J Pers Assess.
2008;90:521-3.
74 Johnson ME, Neal DB, Brems C, Fisher DG. Depression as
measured by the Beck Depression Inventory-II among injecting
drug users. Assessment. 2006;13:168-77.
75 Krefetz DG, Steer RA, Gulab NA, Beck AT. Convergent validity of
the Beck depression inventory-II with the reynolds adolescent
depression scale in psychiatric inpatients. J Pers Assess.
2002;78:451-60.
76 Krefetz DG, Steer RA, Kumar G. Lack of age differences in the
Beck Depression Inventory-II scores of clinically depressed
adolescent outpatients. Psychol Rep. 2003;92:489-97.
77 Kumar G, Steer RA, Teitelman KB, Villacis L. Effectiveness of Beck
Depression Inventory-II subscales in screening for major depres-
sive disorders in adolescent psychiatric inpatients. Assessment.
2002;9:164-70.
78 Kung S, Alarcon RD, Williams MD, Poppe KA, Jo Moore M, Frye
MA. Comparing the Beck Depression Inventory-II (BDI-II) and
Patient Health Questionnaire (PHQ-9) depression measures in an
integrated mood disorders practice. J Affect Disord. 2013;145:
341-3.
79 Lindsay WR, Skene DD. The Beck Depression Inventory II and the
Beck Anxiety Inventory in people with intellectual disabilities: factor
analyses and group data. J Appl Res Intellect Disabil. 2007;20:
401-8.
80 O’Hara MM, Sprinkle SD, Ricci NA. Beck Depression Inventory-II:
College population study. Psychol Rep. 1998;82:1395-401.
81 Osman A, Barrios FX, Gutierrez PM, Williams JE, Bailey J.
Psychometric properties of the Beck Depression Inventory-II in
nonclinical adolescent samples. J Clin Psychol. 2008;64:83-102.
82 Palmer EJ, Binks C. Psychometric properties of the Beck
Depression Inventory-II with incarcerated male offenders aged
18-21 years. Crim Behav Ment Health. 2008;18:232-42.
83 Perry AE, Gilbody S. Detecting and predicting self-harm behaviour
in prisoners: a prospective psychometric analysis of three instru-
ments. Soc Psychiatry Psychiatr Epidemiol. 2009;44:853-61.
84 Quilty LC, Zhang KA, Bagby RM. The latent symptom structure of
the Beck Depression Inventory-II in outpatients with major depres-
sion. Psychol Assess. 2010;22:603-8.
85 Sanz J, Garcia-Vera MP, Espinosa R, Fortu´n M, Va´zquerz C.
Adaptacio´n espan˜ola del Inventario para la Depresio´n de Beck-II
(BDI-II): 3. Propiedades psicome´tricas en pacientes con trastornos
psicolo´gicos. Clin Salud. 2005;16:121-42.
86 Seignourel PJ, Green C, Schmitz JM. Factor structure and
diagnostic efficiency of the BDI-II in treatment-seeking substance
users. Drug Alcohol Depend. 2008;93:271-8.
87 Steer RA, Kumar G, Ranieri WF, Beck AT. Use of the Beck
Depression Inventory-II with adolescent psychiatric outpatients. J
Psychopathol Behav Assess. 1998;20:127-37.
88 Steer RA, Ball R, Ranieri WF, Beck AT. Dimensions of the Beck
Depression Inventory-II in clinically depressed outpatients. J Clin
Psychol. 1999;55:117-28.
89 Steer RA, Rissmiller DJ, Beck AT. Use of the Beck Depression
Inventory-II with depressed geriatric inpatients. Behav Res Ther.
2000;38:311-8.
90 van Noorden MS, van Fenema EM, van der Wee NJ, Zitman FG,
Giltay EJ. Predicting outcome of depression using the depressive
symptom profile: the Leiden Routine Outcome Monitoring Study.
Depress Anxiety. 2012;29:523-30.
91 VanVoorhis CRW, Blumentritt TL. Psychometric properties of the
Beck Depression Inventory-II in a clinically-identified sample of
Mexican American adolescents. J Child Fam Stud. 2007;16:789-98.
92 Arnau RC, Meagher MW, Norris MP, Bramson R. Psychometric
evaluation of the Beck Depression Inventory-II with primary care
medical patients. Health Psychol. 2001;20:112-9.
93 Bunevicius A, Staniute M, Brozaitiene J, Bunevicius R. Diagnostic
accuracy of self-rating scales for screening of depression in
coronary artery disease patients. J Psychosom Res. 2012;72:22-5.
94 Carney CE, Ulmer C, Edinger JD, Krystal AD, Knauss F. Assessing
depression symptoms in those with insomnia: an examination of the
Beck Depression Inventory second edition (BDI-II). J Psychiatr Res.
2009;43:576-82.
95 Carvalho Bos S, Pereira AT, Marques M, Maia B, Soares MJ,
Valente J, et al. The BDI-II factor structure in pregnancy
and postpartum: Two or three factors? Eur Psychiatry.
2009;24:334-40.
96 Chilcot J, Norton S, Wellsted D, Almond M, Davenport A, Farrington
K. A confirmatory factor analysis of the Beck Depression Inventory-
II in end-stage renal disease patients. J Psychosom Res.
2011;71:148-53.
97 Chung ML, Pressler SJ, Dunbar SB, Lennie TA, Moser DK.
Predictors of depressive symptoms in caregivers of patients with
heart failure. J Cardiovasc Nurs. 2010;25:411-9.
98 Corbie`re M, Bonneville-Roussy A, Franche RL, Coutu MF,
Choiniere M, Durand MJ, et al. Further validation of the BDI-II
among people with chronic pain originating from musculoskeletal
disorders. Clin J Pain. 2011;27:62-9.
99 del Pin˜o Pe´rez A, Iba´n˜ez Ferna´ndez I, Bosa Ojeda F, Dorta
Gonza´lez R, Gaos Miezoso MT. [Factor models of the Beck
Depression Inventory-II. Validation with coronary patients and a
critique of Ward’s model]. Psicothema. 2012;24:127-32.
100 Di Benedetto M, Lindner H, Hare DL, Kent S. Depression following
acute coronary syndromes: a comparison between the Cardiac
Depression Scale and the Beck Depression Inventory II. J
Psychosom Res. 2006;60:13-20.
101 Grothe KB, Dutton GR, Jones GN, Bodenlos J, Ancona M, Brantley
PJ. Validation of the Beck Depression Inventory-II in a low-income
African American sample of medical outpatients. Psychol Assess.
2005;17:110-4.
102 Dutton GR, Grothe KB, Jones GN, Whitehead D, Kendra K,
Brantley PJ. Use of the Beck Depression Inventory-II with African
American primary care patients. Gen Hosp Psychiatry.
2004;26:437-42.
Review of Beck Depression Inventory-II 429
Rev Bras Psiquiatr. 2013;35(4)
103 Frasure-Smith N, Lespe´rance F. Depression and anxiety as
predictors of 2-year cardiac events in patients with stable coronary
artery disease. Arch Gen Psychiatry. 2008;65:62-71.
104 Hamid H, Abu-Hijleh NS, Sharif SL, Raqab ZM, Mas’ad D, Abbas A.
A primary care study of the correlates of depressive symptoms
among Jordanian women. Transcult Psychiatry. 2004;41:487-96.
105 Harris CA, D’Eon JL. Psychometric properties of the Beck
Depression Inventory--second edition (BDI-II) in individuals with
chronic pain. Pain. 2008;137:609-22.
106 Hayden MJ, Brown WA, Brennan L, O’Brien PE. Validity of the Beck
Depression Inventory as a screening tool for a clinical mood
disorder in bariatric surgery candidates. Obes Surg. 2012;22:
1666-75.
107 Jamroz-Wisniewska A, Papuc E, Bartosik-Psujek H, Belniak E,
Mitosek-Szewczyk K, Stelmasiak Z. [Validation of selected aspects
of psychometry of the Polish version of the Multiple Sclerosis
Impact Scale 29 (MSIS-29)]. Neurol Neurochir Pol. 2007;41:
215-22.
108 Jones JE, Hermann BP, Woodard JL, Barry JJ, Gilliam F, Kanner
AM, et al. Screening for major depression in epilepsy with common
self-report depression inventories. Epilepsia. 2005;46:731-5.
109 Kirsch-Darrow L, Marsiske M, Okun MS, Bauer R, Bowers D.
Apathy and depression: separate factors in Parkinson’s disease. J
Int Neuropsychol Soc. 2011;17:1058-66.
110 Lopez MN, Pierce RS, Gardner RD, Hanson RW. Standardized
Beck Depression Inventory-II scores for male veterans coping with
chronic pain. Psychol Serv. 2013;10:257-63.
111 Low GD, Hubley AM. Screening for depression after cardiac events
using the Beck Depression Inventory-II and the Geriatric
Depression Scale. Soc Indic Res. 2007;82:527-43.
112 Wan Mahmud WM, Awang A, Herman I, Mohamed MN. Analysis of
the psychometric properties of the Malay version of Beck
Depression Inventory II (BDI-II) among postpartum women in
Kedah, North West of Peninsular Malaysia. Malays J Med Sci.
2004;11:19-25.
113 Ooms E, Meganck R, Vanheule S, Vinck B, Watelet JB, Dhooge I.
Tinnitus severity and the relation to depressive symptoms: a critical
study. Otolaryngol Head Neck Surg. 2011;145:276-81.
114 Patterson AL, Morasco BJ, Fuller BE, Indest DW, Loftis JM, Hauser
P. Screening for depression in patients with hepatitis C using the
Beck Depression Inventory-II: do somatic symptoms compromise
validity? Gen Hosp Psychiatry. 2011;33:345-62.
115 Penley JA, Wiebe JS, Nwosu A. Psychometric properties of the
Spanish Beck Depression Inventory-II in a medical sample. Psychol
Assess. 2003;15:569-77.
116 Poole H, Bramwell R, Murphy P. Factor Structure of the Beck
Depression Inventory-II in patients With chronic pain. Clin J Pain.
2006;22:790-8.
117 Poole H, White S, Blake C, Murphy P, Bramwell R. Depression in
chronic pain patients: prevalence and measurement. Pain Pract.
2009;9:173-80.
118 Rampling J, Mitchell AJ, Von Oertzen T, Docker J, Jackson J, Cock
H, et al. Screening for depression in epilepsy clinics. A comparison
of conventional and visual-analog methods. Epilepsia.
2012;53:1713-21.
119 Siegert RJ, Tennant A, Turner-Stokes L. Rasch analysis of the
Beck Depression Inventory-II in a neurological rehabilitation
sample. Disabil Rehabil. 2009;32:8-17.
120 Su KP, Chiu TH, Huang CL, Ho M, Lee CC, Wu PL, et al. Different
cutoff points for different trimesters? The use of Edinburgh
Postnatal Depression Scale and Beck Depression Inventory to
screen for depression in pregnant Taiwanese women. Gen Hosp
Psychiatry. 2007;29:436-41.
121 Thombs BD, Ziegelstein RC, Beck CA, Pilote L. A general factor
model for the Beck Depression Inventory-II: validation in a sample
of patients hospitalized with acute myocardial infarction. J
Psychosom Res. 2008;65:115-21.
122 Tully PJ, Winefield HR, Baker RA, Turnbull DA, de Jonge P.
Confirmatory factor analysis of the Beck Depression Inventory-II
and the association with cardiac morbidity and mortality after
coronary revascularization. J Health Psychol. 2011;16:584-95.
123 Turner A, Hambridge J, White J, Carter G, Clover K, Nelson L,
et al. Depression screening in stroke: a comparison of
alternative measures with the structured diagnostic interview for
the diagnostic and statistical manual of mental disorders, fourth
edition (major depressive episode) as criterion standard. Stroke.
2012;43:1000-5.
124 Viljoen JL, Iverson GL, Griffiths S, Woodward TS. Factor structure
of the Beck Depression Inventory - II in a medical outpatient
sample. J Clin Psychol Med Settings. 2003;10:289-91.
125 Warmenhoven F, van Rijswijk E, Engels Y, Kan C, Prins J, van
Weel C, et al. The Beck Depression Inventory (BDI-II) and a single
screening question as screening tools for depressive disorder in
Dutch advanced cancer patients. Support Care Cancer.
2012;20:319-24.
126 Williams JR, Hirsch ES, Anderson K, Bush AL, Goldstein SR, Grill
S, et al. A comparison of nine scales to detect depression in
Parkinson disease: which scale to use? Neurology. 2012;78:998-
1006.
127 Huprich SK, Roberts CR. The two-week and five-week depend-
ability and stability of the depressive personality disorder inventory
and its association with current depressive symptoms. J Pers
Assess. 2012;94:205-9.
128 Yin P, Fan X. Assessing the reliability of Beck Depression Inventory
scores: reliability generalization. Educ Psychol Meas. 2000;60:
201-23.
129 Longwell BT, Truax P. The differential effects of weekly, monthly,
and bimonthly administrations of the Beck Depression Inventory-II:
psychometric properties and clinical implications. Behav Ther.
2005;36:265-75.
130 Cronbach LJ. Essentials of psychological testing. 3nd ed. New
York: Harper and Row; 1990.
131 Alansari BM. Beck depression inventory (BDI-II) items character-
istics among undergraduate students of nineteen islamic countries.
Soc Behav Pers. 2005;33:675-84.
132 Silverstein B, Edwards T, Gamma A, Ajdacic-Gross V, Rossler W,
Angst J. The role played by depression associated with somatic
symptomatology in accounting for the gender difference in the
prevalence of depression. Soc Psychiatry Psychiatr Epidemiol.
2013;48:257-63.
133 Cronbach LJ. Coefficient alpha and the internal structure of tests.
Psychometrika. 1951;16:297-334.
134 Hambleton RK, Swaminathan H, Rogers HJ. Fundamentals of item
response theory. Newbury Park: Sage; 1991.
135 Hambrick JP, Rodebaugh TL, Balsis S, Woods CM, Mendez JL,
Heimberg RG. Cross-ethnic measurement equivalence of mea-
sures of depression, social anxiety, and worry. Assessment.
2010;17:155-71.
136 Wu PC, Huang TW. Person heterogeneity of the BDI-II-C and its
effects on dimensionality and construct validity: using mixture item
response models. Meas Eval Couns Develop. 2010;43:155-67.
137 Beck AT, Steer RA, Ball R, Ranieri WF. Comparison of Beck
Depression Inventories –IA and II in psychiatric outpatients. J Pers
Assess. 1996;67:588-97.
138 Clark LA, Watson D. Tripartite model of anxiety and depression:
psychometric evidence and taxonomic implications. J Abnorm
Psychol. 1991;100:316-36.
139 Watson D, Clark LA, Carey G. Positive and negative affectivity and
their relation to anxiety and depressive disorders. J Abnorm
Psychol. 1988;97:346-53.
140 Watson D. Differentiating the mood and anxiety disorders: a
quadripartite model. Annu Rev Clin Psychol. 2009;5:221-47.
141 Cicchetti DV. Guidelines, criteria, and rules of thumb for evaluating
normed and standardized assessment instruments in psychology.
Psychol Assess. 1994;6:284-90.
142 Byrne BM. Factor analytic models: viewing the structure of an
assessment instrument from three perspectives. J Pers Assess.
2005;85:17-32.
143 Moran PW, Lambert MJ. A review of current assessment tools for
monitoring changes in depression. In: Lambert MJ, Christensen
ER, DeJulio SS, editors. The assessment of psychotherapy
outcome. New York: Wiley; 1983. p. 263-303.
144 Richter P, Werner J, Heerlein A, Kraus A, Sauer H. On the validity
of the Beck Depression Inventory. A review. Psychopathology.
1998;31:160-8.
145 Maj M. Development and validation of the current concept of major
depression. Psychopathology. 2012;45:135-46.
YP Wang & C Gorenstein430
Rev Bras Psiquiatr. 2013;35(4)
146 Smith GT. On construct validity: issues of method and measure-
ment. Psychol Assess. 2005;17:396-408.
147 Strauss ME, Smith GT. Construct validity: advances in theory and
methodology. Annu Rev Clin Psychol. 2009;5:1-25.
148 Byrne BM. Structural equation modeling with LISREL, PRELIS and
SIMPLIS: basic concepts, applications and programming. Mahwah:
Lawrence Erlbaum Associates; 1998.
149 Cohen A. The underlying structure of the Beck Depression
Inventory II: A multidimensional scaling approach. J Res Pers.
2008;42:779-86.
150 Byrne BM, Stewart SM, Kennard BD, Lee PWH. The Beck
Depression Inventory-II: testing for measurement equivalence and
factor mean differences across Hong Kong and American
adolescents. Int J Testing. 2007;7:293-309.
Review of Beck Depression Inventory-II 431
Rev Bras Psiquiatr. 2013;35(4)
